Restart Life Sciences Corp. (CSE: HEAL)

Restart Life Sciences Balance Sheet

Financials in millions CAD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	0.01	0.01	0.27	0.22	2.14	0.09
Short-Term Investments	-	-	-	-	0.01	0.76
Cash & Short-Term Investments	0.01	0.01	0.27	0.22	2.14	0.85
Cash Growth	-30.86%	-96.97%	21.85%	-89.78%	152.60%	-57.56%
Accounts Receivable	-	-	-	-	0.02	0.01
Other Receivables	0	0.01	0.01	0.07	-	-
Receivables	0	0.01	0.01	0.07	0.02	0.01
Inventory	-	-	-	-	0.01	0.02
Prepaid Expenses	-	0	0.01	0.04	0.42	0.01
Total Current Assets	0.02	0.02	0.28	0.33	2.58	0.88
Property, Plant & Equipment	0.01	0.01	0.01	0.02	0.02	0.03
Long-Term Investments	-	-	-	-	0.44	5.67
Total Assets	0.03	0.03	0.3	0.88	3.05	6.58
Accounts Payable	0.61	0.39	0.12	0.4	0.32	0.29
Accrued Expenses	0.41	0.45	0.14	0.02	0.07	0.04
Total Current Liabilities	1.07	0.84	0.26	0.42	0.38	0.33
Total Liabilities	1.07	0.84	0.26	0.42	0.38	0.33
Common Stock	50.26	50.19	50.07	48.37	48.24	27.49
Retained Earnings	-59.52	-59.29	-58.06	-55.6	-52.91	-27.68
Comprehensive Income & Other	8.22	8.29	8.04	7.69	7.34	6.45
Shareholders' Equity	-1.05	-0.81	0.04	0.46	2.66	6.26
Total Liabilities & Equity	0.03	0.03	0.3	0.88	3.05	6.58
Net Cash (Debt)	-0.05	0.01	0.27	0.22	2.14	0.85
Net Cash Growth	-	-96.97%	21.85%	-89.78%	152.60%	-57.56%
Net Cash Per Share	-0.00	0.00	0.01	0.01	0.21	0.13
Filing Date Shares Outstanding	29.66	29.63	29.41	28.45	22.23	6.43
Total Common Shares Outstanding	29.66	29.43	29.02	22.3	22.23	6.43
Working Capital	-1.06	-0.82	0.03	-0.09	2.2	0.56
Book Value Per Share	-0.04	-0.03	0.00	0.02	0.12	0.97
Tangible Book Value	-1.05	-0.81	0.04	0.46	2.66	6.26
Tangible Book Value Per Share	-0.04	-0.03	0.00	0.02	0.12	0.97
Machinery	0.06	0.06	0.06	0.06	0.06	0.06

Source: S&P Capital IQ. Standard template. Financial Sources.